Klingenstein Fields & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-28,120
| Closed | -$934K | – | 224 |
|
2017
Q2 | $934K | Hold |
28,120
| – | – | 0.04% | 132 |
|
2017
Q1 | $902K | Sell |
28,120
-7,191
| -20% | -$231K | 0.04% | 133 |
|
2016
Q4 | $1.28M | Sell |
35,311
-69,643
| -66% | -$2.52M | 0.06% | 120 |
|
2016
Q3 | $4.83M | Sell |
104,954
-87,893
| -46% | -$4.04M | 0.22% | 70 |
|
2016
Q2 | $9.69M | Buy |
192,847
+38,322
| +25% | +$1.92M | 0.45% | 55 |
|
2016
Q1 | $8.27M | Buy |
154,525
+149,145
| +2,772% | +$7.98M | 0.41% | 57 |
|
2015
Q4 | $353K | Hold |
5,380
| – | – | 0.02% | 169 |
|
2015
Q3 | $304K | Hold |
5,380
| – | – | 0.02% | 179 |
|
2015
Q2 | $318K | Hold |
5,380
| – | – | 0.01% | 193 |
|
2015
Q1 | $335K | Hold |
5,380
| – | – | 0.01% | 191 |
|
2014
Q4 | $309K | Sell |
5,380
-60
| -1% | -$3.45K | 0.01% | 197 |
|
2014
Q3 | $292K | Sell |
5,440
-800
| -13% | -$42.9K | 0.01% | 203 |
|
2014
Q2 | $327K | Buy |
6,240
+140
| +2% | +$7.34K | 0.01% | 202 |
|
2014
Q1 | $322K | Sell |
6,100
-1,100
| -15% | -$58.1K | 0.01% | 205 |
|
2013
Q4 | $289K | Hold |
7,200
| – | – | 0.01% | 263 |
|
2013
Q3 | $272K | Sell |
7,200
-1,500
| -17% | -$56.7K | 0.01% | 262 |
|
2013
Q2 | $341K | Buy |
+8,700
| New | +$341K | 0.01% | 248 |
|